Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Retained Earnings (2010 - 2026)

Talphera (TLPH) posted Retained Earnings of $492.7 million for Q2 2026, little changed on a QoQ basis from $492.5 million in Q1 2026, and up 4.86% year-over-year from $469.9 million in Q2 2025.

Analysis

Talphera (TLPH) Retained Earnings (2010 - 2026) Analysis & Trends

Talphera has reported Retained Earnings for 17 years, with the latest figure at $492.7 million in Q2 2026.

  • On a quarterly basis, Retained Earnings rose 4.86% year-over-year to $492.7 million in Q2 2026; TTM through Jun 2026 was $492.7 million, a 4.86% increase from a year earlier, with the FY2025 full-year figure at $488.5 million, up 5.01% from the prior year.
  • Retained Earnings was $492.7 million for Q2 2026 at Talphera, roughly flat from $492.5 million in the prior quarter.
  • The five-year high for Retained Earnings was $492.7 million in Q2 2026, with the low at -$482.3 million in Q1 2022.
  • Average Retained Earnings over 5 years is $412.5 million, with a median of $464.6 million recorded in 2024.
  • The largest YoY upside for Retained Earnings was 197.22% in 2022 against a maximum downside of 7.78% in 2022.
  • Over 5 years, Retained Earnings stood at $447.6 million in 2022, then rose by 2.39% to $458.3 million in 2023, then advanced by 1.51% to $465.2 million in 2024, then rose by 5.01% to $488.5 million in 2025, then gained by 0.87% to $492.7 million in 2026.
  • The last three Retained Earnings figures came in at $492.7 million (Q2 2026), $492.5 million (Q1 2026), and $488.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 558.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -6.33 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.13 Bn
10 Talphera 92.90 Mn 92.90 Mn - 492.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 492.74 Mn
Mar 31, 2026 492.50 Mn
Dec 31, 2025 488.51 Mn
Sep 30, 2025 486.88 Mn
Jun 30, 2025 469.92 Mn
Mar 31, 2025 465.41 Mn
Dec 31, 2024 465.21 Mn
Sep 30, 2024 464.98 Mn
Jun 30, 2024 464.72 Mn
Mar 31, 2024 464.50 Mn
Dec 31, 2023 458.31 Mn
Sep 30, 2023 458.00 Mn
Jun 30, 2023 448.76 Mn
Mar 31, 2023 448.21 Mn
Dec 31, 2022 447.64 Mn
Sep 30, 2022 445.56 Mn
Jun 30, 2022 444.59 Mn
Mar 31, 2022 -482.26 Mn
Dec 31, 2021 -473.58 Mn
Sep 30, 2021 -465.67 Mn